Welcome to our dedicated page for CoreWeave SEC filings (Ticker: CRWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CoreWeave, Inc. filings document the regulatory record for an AI cloud infrastructure company listed on Nasdaq with Class A common stock. The company’s 8-K reports cover operating results, customer cloud-capacity agreements, private placements of equity securities, senior notes, credit facilities, and related guarantees or collateral arrangements.
Proxy materials disclose annual meeting matters, stockholder voting items, board governance, executive compensation, and equity-award information. Capital-structure filings describe senior unsecured notes due 2031, subsidiary guarantees, private placement registration rights, and debt facilities used to finance GPU servers and related infrastructure for customer contracts.
The Vanguard Group has filed a Schedule 13G showing beneficial ownership of CoreWeave Inc common stock. Vanguard reports beneficial ownership of 27,920,979 shares, representing 7.22% of the class as of the event date of 12/31/2025.
Vanguard has shared voting power over 1,632,008 shares and shared dispositive power over 27,920,979 shares, with no sole voting or dispositive power. The filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of CoreWeave.
The filing explains that Vanguard’s clients, including registered investment companies and other managed accounts, have the right to receive dividends and sale proceeds, and that no single other person has an interest in more than 5% of the class. Vanguard also notes an internal realignment on January 12, 2026, after which certain subsidiaries are expected to report beneficial ownership separately.
CoreWeave, Inc. shareholder Jeffrey R. Baker has filed a Notice of Proposed Sale of Securities on Form 144 covering 5,143 shares of Class A common stock. The filing lists an aggregate market value of 533,759.6 for these shares and an approximate sale date of 01/29/2026, with sales to be placed through Morgan Stanley Smith Barney LLC on the NASDAQ.
The securities were acquired from the issuer on 01/29/2026 as compensation in the form of restricted stock units, with the consideration described as Compensation. The notice also reports that during the past three months, Baker sold 6,398 Class A common shares on 10/29/2025 for gross proceeds of 862,450.4, while the issuer had 386,401,201 shares outstanding. By signing, the seller represents they are not aware of undisclosed material adverse information about CoreWeave’s current or prospective operations.
CoreWeave, Inc.’s Chief Development Officer McBee Brannin reported indirect trust transactions in Class A and Class B shares on January 26, 2026. Canis Major 2025 GRAT and Canis Minor 2025 GRAT converted Class B Common Stock into Class A Common Stock and then sold Class A shares in multiple open‑market trades.
The sales were made under a Rule 10b5‑1 trading plan adopted on September 2, 2025, at weighted average prices with ranges from about $98.18 to $108.54 per share, as described in the footnotes. The filing also shows significant indirect holdings of Class B Common Stock in the two GRATs and additional indirect ownership through the reporting person’s spouse and child.
CoreWeave, Inc. insider activity centers on trusts managed by Chief Development Officer McBee Brannin. On January 26, 2026, the Canis Major 2025 Family Trust LLC and Canis Minor 2025 Family Trust LLC each converted 1,000 shares of Class B Common Stock into 1,000 shares of Class A Common Stock.
Each trust then sold those Class A shares in a series of market transactions, with weighted average prices reported between $98.584 and $106.5193, under a Rule 10b5-1 trading plan adopted on September 2, 2025. After these trades, the trusts no longer held those specific Class A shares but continued to beneficially own 111,600 and 125,000 Class B shares, respectively.
CoreWeave, Inc.’s Chief Development Officer, Brannin McBee, reported trust-related insider activity involving Class A and Class B Common Stock. A trust associated with his family converted 25,000 shares of Class B Common Stock into an equal number of Class A shares on January 26, 2026.
On the same date, the Brannin J. McBee 2022 Irrevocable Trust sold multiple blocks of Class A Common Stock at weighted average prices ranging from about $98 to $108 per share, leaving it with no shares after the final reported sale. Additional small sales of Class A Common Stock were made by the Canis Major Trust, which continues to hold tens of thousands of shares afterward.
The filing notes that at least one of the sale transactions was executed under a Rule 10b5-1 trading plan adopted on September 2, 2025, indicating a pre-arranged schedule for disposing of shares by the trusts associated with McBee’s family.
CoreWeave, Inc.’s Chief Development Officer McBee Brannin reported multiple insider transactions involving Class A and Class B Common Stock on January 26, 2026. Each Class B share is convertible into one Class A share.
Brannin converted Class B shares into Class A and then sold portions of the resulting Class A Common Stock in a series of trades executed under a pre-arranged Rule 10b5-1 trading plan. The reported weighted-average sale prices ranged from the high $90s to about $108 per share, leaving 248,664 Class A shares held directly after these sales.
Separately, transactions were reported for Canis Major 2024 Irrevocable Trust LLC, an entity for which Brannin serves as manager. That trust converted 3,000 Class B shares into Class A and then sold its reported Class A position in multiple trades across similar price ranges.
CRWV insiders have filed a Rule 144 notice covering the planned sale of 50,000 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $5,443,000, and will trade on NASDAQ.
The securities were originally acquired as founder shares on November 13, 2017. The filing also lists multiple sales of common stock during the past three months by Michael Intrator, Omnadora Capital LLC, and a non-affiliate donee under Rule 10b5-1 trading arrangements, reflecting ongoing programmed selling activity.
CRWV has a Form 144 notice indicating an intended sale of 32,456 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $3,533,160.16, on or after 01/28/2026 on NASDAQ.
The shares were acquired as founder shares from the issuer on 11/13/2017. The filing also lists recent Rule 10b5-1 and other sales of CRWV common stock over the past three months, including individual transactions such as 32,455 shares sold for $2,904,243.32 and 50,000-share sales by OMNADORA CAPITAL LLC.
The table notes 386,401,201 common shares outstanding for context.
CRWV insiders filed a notice under Rule 144 covering the proposed sale of 8,335 common shares, with an aggregate market value of $774,988.30, through Morgan Stanley Smith Barney on NASDAQ around 01/26/2026. The issuer reports 386,401,201 common shares outstanding.
The shares to be sold are identified as founders shares acquired from the issuer on 02/25/2019. The filing also lists extensive 10b5‑1 sales of CRWV common stock over the past three months by Brannin McBee, several related trusts and entities, and a non‑affiliate donee, with individual transactions ranging from hundreds to over one hundred thousand shares and gross proceeds from tens of thousands to many millions of dollars per entry.
An existing shareholder has filed a notice of intent to sell 25,000 shares of common stock through Morgan Stanley Smith Barney LLC on or after January 26, 2026 on NASDAQ, with a stated aggregate market value of $2,324,500. The issuer reports 386,401,201 common shares outstanding.
The shares to be sold were acquired as founder shares from the issuer on February 25, 2019. The notice also lists extensive recent sales under Rule 10b5-1 plans by Brannin J. McBee, related trusts and entities, and a non-affiliate donee, including a sale of 257,733 common shares for $19,592,527.61 on December 1, 2025. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer’s operations.